Research
Trials, publications and work in progress
Principal Investigator on a national real-world insulin study, investigator on two more, and a continuing publication record in Indian diabetes and internal medicine journals. ORCID is the authoritative list.
Clinical studies
Principal Investigator
PRIMARY
A multi-year real-world study of basal insulin therapy in India (Sanofi). Site PI through study completion; clinical study report 2025.
Investigator
TRANSFORM-INDIA
Multicentre real-world obesity study (Emcure Pharmaceuticals with QREC Clinical Research). 2026 to present.
Investigator
OSCAR
Novo Nordisk, 2025, including cardiovascular risk assessment work.
Selected publications
Active pipeline, 2026
- Three manuscripts in preparation or under review: case reports on insulin-pump-managed type 2 diabetes with residual cardiovascular risk and on thyroid-metabolic care, and a narrative review of dietary fructose co-authored with a clinical pharmacology specialist.
- A ten-survey national physician research programme on diabetes and obesity practice patterns, covering GLP-1 prescribing, treatment inertia, insulin initiation and diabetes technology. Fieldwork underway.
- Patient-reported barriers to diabetes self-management: a single-centre survey of 138 respondents, under analysis for publication.
For CROs and medical affairs teams. He takes site-investigator roles in diabetes, obesity and cardiometabolic studies, and sits on advisory boards, expert panels and consensus meetings. Caspian Healthcare handles more than 20,000 consultations a year, which makes it viable as a single-centre real-world site.